Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
IRCT20210511051268N1Phase 3Completed
Phase 3, randomised, double-blind trial of acetaminophen in None (3 arms), sponsored by Tehran University of Medical Sciences. Primary endpoint: Extent of local pain after intravenous injection of propofol. Started Jun 2021; status: completed.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on IRCT20210511051268N1.